Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning

Current Opinion in Hematology · Published 2026-06-25 · DOI 10.1097/moh.0000000000000941

Free full text

Authors (2)

Evan Kidder, Nirav Dhanesha

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kidder, E., Dhanesha, N. (2026). Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning. Current Opinion in Hematology. https://doi.org/10.1097/moh.0000000000000941

Related articles

• Bidirectional relationship between metabolic and thrombotic disease mechanisms · Current Opinion in Hematology · 2026 · Same journal
• Antithymocyte globulin and posttransplant cyclophosphamide in graft vs. host disease prophylaxis: comparison or combination · Current Opinion in Hematology · 2025 · Same journal
• The role of stem cell transplantation in the modern management of multiple myeloma · Current Opinion in Hematology · 2025 · Same journal
• Clinical applications of PET imaging for evaluating treatment-induced vascular toxicity in oncology · Current Opinion in Hematology · 2026 · Same journal
• Messengers of coagulopathy: complement-carrying extracellular vesicles in SARS-CoV-2 infection · Current Opinion in Hematology · 2026 · Same journal
• Red cells: not only hemoglobin – plasma membranes are also of paramount importance · Current Opinion in Hematology · 2025 · Same journal
• Roles of megakaryocytes and platelets in myeloproliferative neoplasms · Current Opinion in Hematology · 2026 · Same journal
• Advances in the pathophysiology and treatment of anaemia in multiple myeloma · Current Opinion in Hematology · 2026 · Same journal
• G protein-coupled receptor-mediated platelet thrombus formation · Current Opinion in Hematology · 2026 · Same journal
• Contemporary data in myeloproliferative neoplasm-unclassifiable: mutational landscape and management of the ‘unclassifiable’ · Current Opinion in Hematology · 2025 · Same journal